Bruker Corporation (Nasdaq: BRKR) announced today that it will unveil significant advancements in spatial biology at the 2025 ...

Good day, and welcome to the Bruker Corporation Fourth Quarter 2024 ... consisting of 4.2% organic growth in Scientific Instruments and 1.9% organic growth at BEST, net of eliminations.

Bruker (BRKR) reported $979.6 million in revenue for the quarter ended December 2024, representing a year-over-year increase of 14.6%. EPS of $0.76 for the same period compares to $0.70 a year ago.

2025 Non-GAAP EPS Guidance: $2.67 to $2.72, representing 11% to 13% growth. Bruker Corp (NASDAQ:BRKR) reported a strong Q4 2024 with a 14.6% year-over-year increase in revenues, reaching $979.6 ...

Major players in the market Include Bruker, Nikon, Olympus, Zeiss, Oxford Instruments and Etaluma. Due to the presence of prominent players and increasing expenditure in R&D, North America has the ...

Sign up for CNN’s Wonder Theory science newsletter. Explore the universe with news on fascinating discoveries, scientific advancements and more. NASA’s twin ...

Georgia Tech is readying for its 27th annual Guthman Musical Instrument Competition, and has officially announced its choice of finalists highlighting some of the year’s weirdest and most ...

Bruker Corporation (NASDAQ:BRKR) stands second among the best medical technology stocks to buy according to analysts. It is a leading provider of scientific instruments and analytical solutions ...

Said trucks were produced with an incorrectly programmed instrument panel cluster software that prevented the gauges and telltales to illuminate at startup. As expected, a new software version was ...

Bruker Corporation (NASDAQ:BRKR) focuses on developing, manufacturing, and distributing scientific instruments, and analytical and diagnostic solutions. The one-month return of Bruker Corporation ...

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the research tools & consumables stocks, including ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...